PeptidePedia The community reference

Weight regain after discontinuation: difference between revisions

Diff·revision 11 → 12·04:40, 5 Feb 2025

Difference between revision 11 and revision 12 of Weight regain after discontinuation. 6 lines changed; the page grew by 126 bytes.

Revision 11 — 17:13, 16 Jan 2025
MTC_Marisol (talk)
add the placebo rate next to the treatment rate
3,570 bytes ±0
Revision 12 — 04:40, 5 Feb 2025
NauseaNoor (talk)
add the note that titration exists partly to manage these effects
3,696 bytes +126
33<ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref>33<ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref>
3434
+35== See also ==
+36* [[STEP trial programme]]
+37* [[SURMOUNT trial programme]]
+38* [[Missed dose]]
+39* [[Body composition assessment]]
+40
35{{DEFAULTSORT:Weight regain after discontinuation}}41{{DEFAULTSORT:Weight regain after discontinuation}}
36[[Category:Discontinuation and maintenance]]42[[Category:Discontinuation and maintenance]]